Rosalee Hellberg, an associate professor in Chapman University's Food Science Program, and her research team have made a ...

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant ...

Rates of babesiosis, a tick-borne parasitic disease, increased an average of 9% per year in the United States between 2015 ...

Waiting more than 4 hours in emergency care for treatment is linked to heightened risks of death and a longer hospital stay for hip fracture patients, reveals a single centre study, published online ...

Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, with poorer ...

New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.

Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for more than 20,000 cases of this condition annually in the U.S. alone.

A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three ...

In a bid to combat the rising threat of antibacterial resistance, researchers from the Research Center for Biomas, National Research and Innovation Agency (BRIN), have delved into the characteristics ...

Agriculture is a stressful occupation, and farmers struggle with anxiety and depression at higher levels than the general population.

Researchers from IOCB Prague are furthering the understanding of how medicines work and what it takes to develop their most effective variants.